Neuropsychological and resting-state electroencephalographic markers of older adult neurocognitive adaptability.

OBJECTIVE

This study was undertaken to explore multimethod neurocognitive screening tools to aid in detection of older adults who may be at heightened risk of pathological cognitive decline (preclinical dementia). In so doing, this study advances the theoretical conceptualization of neurocognitive adaptability in the context of aging and dementia.

METHOD

This article reports original data from the baseline measurement occasion of a longitudinal study of healthy, community-dwelling older adults from the Victoria, British Columbia region. Participants were diagnosed as normal, subtle decline, or mild cognitive impairment according to actuarial neuropsychological criteria (adjusted for age only or adjusted for age and premorbid IQ). Diagnostic classification was employed to illustrate group differences in a novel metric of multi-timescale neural adaptability derived from 4-min of resting-state electroencephalographic data collected from each participant (immediately following their neuropsychological evaluation).

RESULTS

Prior findings were replicated; adjusting raw neuropsychological test scores for individual differences in estimated premorbid IQ appeared to increase the sensitivity of standardized clinical tasks to subtle cognitive impairment. Moreover, and consistent with prior neuroscientific research, timescale-specific (i.e. at ∼12-20 ms timescales) differences in resting-state neural adaptability appeared to characterize groups who differed in terms of neuropsycholgoical diagnostic classification.

CONCLUSIONS

Recently proposed actuarial neuropsychological criteria for subtle cognitive decline identify older adults who show timescale-specific changes in resting brain function that may signal the onset of preclinical dementia. The subtle decline stage may represent a critical inflection point-partial loss of neurocognitive adaptability-on a pathological aging trajectory. These findings illustrate areas of potential future development in neurocognitive health care.